| | Identification | Back Directory |  | [Name] 
 [(3R,3aS,6aR)-Hydroxyhexahydrofuro[2,3-β]furanyl Succinimidyl Carbonate
 |  | [CAS] 
 253265-97-3
 |  | [Synonyms] 
 [(3R,3aS,6aR)-Hydroxyhexahydrofuro[2,3-β]furanyl Succinimidyl Carbonate
 [(3R,3aS,6aR)-Hydroxyhexahydrofuro[2,3-b]furanyl Succinimidyl Carbonate
 (3R,3aS,6aR)-3-Hydroxyhexahydrofuro[2,3-b]furanyl Succinimidyl Carbonate
 (3R,3AS,6AR)-3-HYDROXYHEXAHYDROFURO(2,3-B)FURANYL SUCCICINAMIDYL CARBONATE
 2,5-Dioxopyrrolidin-1-yl ((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl) carbonate
 1-({[(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yloxy]carbonyl}oxy)pyrrolidine-2,5-dione
 1-[[[[(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl]oxy]carbonyl]oxy]-2,5-pyrrolidinedione
 1-[[[[(3R,3aS,6aR)-Hexahydrofuro[2,3-β]furan-3-yl]oxy]carbonyl]oxy]-2,5-pyrrolidinedione
 Carbonic Acid 2,5-Dioxo-1-pyrrolidinyl [(3R,3aS,6aR)-Hexahydrofuro[2,3-β]furan-3-yl] Ester
 Carbonic Acid 2,5-Dioxo-1-pyrrolidinyl [(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl] Ester
 |  | [EINECS(EC#)] 
 813-811-7
 |  | [Molecular Formula] 
 C11H13NO7
 |  | [MDL Number] 
 MFCD12031467
 |  | [MOL File] 
 253265-97-3.mol
 |  | [Molecular Weight] 
 271.22
 | 
 | Chemical Properties | Back Directory |  | [Appearance] 
 Pale-Yellow Solid
 |  | [Melting point ] 
 122-125℃
 |  | [Boiling point ] 
 391.8±52.0 °C(Predicted)
 |  | [density ] 
 1.51
 |  | [vapor pressure ] 
 0-0Pa at 20-25℃
 |  | [storage temp. ] 
 Sealed in dry,2-8°C
 |  | [solubility ] 
 Chloroform (Slightly), Ethyl Acetate (Slightly)
 |  | [form ] 
 Solid
 |  | [color ] 
 White
 |  | [InChI] 
 InChI=1S/C11H13NO7/c13-8-1-2-9(14)12(8)19-11(15)18-7-5-17-10-6(7)3-4-16-10/h6-7,10H,1-5H2/t6-,7-,10+/m0/s1
 |  | [InChIKey] 
 VCFNCYVHQSHFRH-MHYGZLNHSA-N
 |  | [SMILES] 
 C(O[C@H]1CO[C@@]2([H])OCC[C@]21[H])(=O)ON1C(=O)CCC1=O
 |  | [LogP] 
 0.3 at pH7
 | 
 | Hazard Information | Back Directory |  | [Chemical Properties] 
 Pale-Yellow Solid
 |  | [Uses] 
 Darunavir intermediate
 |  | [Synthesis] 
 
 1. 26.3 g of tert-butyl methyl ether, 35.09 g (135 mmol) of N,N'-disuccinimidyl carbonate, and 20.00 g (73.0% content) of (3R,3aS,6aR)-hexahydrofuro[2,3-B]furan-3-ol were mixed at room temperature, and the mixture was heated to 40 °C.
2. 11.89 g (150 mmol) of pyridine was added slowly and dropwise to the reaction mixture at 40 °C.
3. the reaction mixture was stirred at 40 °C for 22 hours.
4. Upon completion of the reaction, the reaction solution was cooled to 20 °C and 73.0 g of 2-propanol was slowly added dropwise at 20 °C to precipitate the target product 2,5-dioxopyrrolidin-1-yl ((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl) carbonate.
5. The mixture was further cooled to 0-5°C and stirred at that temperature for 19 hours.
6. The precipitated target product was collected by filtration and washed with an appropriate solvent to give 27.83 g of product (97.8% content, 90% yield, enantiomeric excess >99.9% ee).
7. for the isolation of diastereoisomers, 30.0 g of tert-butyl methyl ether, 11.87 g of (3R,3aS,6aR)-hexahydrofuro[2,3-B]furan-3-ol containing 84.3% of the diastereoisomers, and the enzyme (CHIRAZYME L-2c, -flyo, Roche Diagnostics) were mixed at 25°C.
8. 3.31 g (38.4 mmol) of ethyl acetate was added dropwise to the mixture and the insoluble material was removed by filtration after stirring at 25 °C for 40 hours.
9. The filtrate was concentrated to give 12.73 g of a mixture containing (3R,3aS,6aR)-hexahydrofuro[2,3-B]furan-3-ol and its 3S,3aS,6aR isomer (90% yield, diastereoisomer ratio 100.0/0.0). |  | [References] 
 [1] Patent: JP2016/150901,  2016,  A. Location in patent: Paragraph 0016; 0017; 0023; 0024
 [2] Journal of Organic Chemistry,  2004,  vol. 69,  # 23,  p. 7822 - 7829
 [3] European Journal of Organic Chemistry,  2016,  vol. 2016,  # 10,  p. 1874 - 1880
 [4] Journal of Medicinal Chemistry,  2005,  vol. 48,  # 6,  p. 1813 - 1822
 [5] Patent: WO2010/23322,  2010,  A1. Location in patent: Page/Page column 29
 | 
 |  |